Evercrisp is a Bay Area biotechnology company focused on the discovery and development of protein-based genome editors as therapeutics for multiple disease areas. This new cutting-edge research space will add tissue culture and instrument labs, open office spaces, conference rooms, and break rooms, expanding and enhancing Evercrisp’s abilities to improve the area of oncology advances.